These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2391396)

  • 1. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration.
    Gupta SK; Manfro RC; Tomlanovich SJ; Gambertoglio JG; Garovoy MR; Benet LZ
    J Clin Pharmacol; 1990 Jul; 30(7):643-53. PubMed ID: 2391396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine kinetics in healthy volunteers.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Gray JA; Van Thiel DH; Sanghvi A; Rosenthal JT
    J Clin Pharmacol; 1987 Mar; 27(3):243-8. PubMed ID: 3680581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine.
    Gomez DY; Wacher VJ; Tomlanovich SJ; Hebert MF; Benet LZ
    Clin Pharmacol Ther; 1995 Jul; 58(1):15-9. PubMed ID: 7628178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction.
    Hebert MF; Roberts JP; Prueksaritanont T; Benet LZ
    Clin Pharmacol Ther; 1992 Nov; 52(5):453-7. PubMed ID: 1424418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-fat meals increase the clearance of cyclosporine.
    Gupta SK; Benet LZ
    Pharm Res; 1990 Jan; 7(1):46-8. PubMed ID: 2300535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine kinetics in renal transplantation.
    Ptachcinski RJ; Venkataramanan R; Rosenthal JT; Burckart GJ; Taylor RJ; Hakala TR
    Clin Pharmacol Ther; 1985 Sep; 38(3):296-300. PubMed ID: 3896612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption kinetics of cyclosporine in healthy volunteers.
    Gupta SK; Benet LZ
    Biopharm Drug Dispos; 1989; 10(6):591-6. PubMed ID: 2611359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cyclosporine G in patients with renal failure.
    Wenk M; Bindschedler M; Costa E; Zuber M; Vozeh S; Thiel G; Abisch E; Keller HP; Beveridge T; Follath F
    Transplantation; 1988 Mar; 45(3):558-61. PubMed ID: 3347936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and clinical tolerance of intravenous and oral cyclosporine in the immediate postoperative period.
    Morse GD; Holdsworth MT; Venuto RC; Gerbasi J; Walshe JJ
    Clin Pharmacol Ther; 1988 Dec; 44(6):654-64. PubMed ID: 3058372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and colonic tissue concentrations of cyclosporine after i.v., oral, and enema administration.
    Sandborn WJ; Strong RM; Forland SC; Chase RE; Cutler RE
    J Clin Pharmacol; 1991 Jan; 31(1):76-80. PubMed ID: 2045532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, inhibition of lymphoblast transformation, and toxicity of cyclosporine in clinically normal pigs.
    Vaden SL; Riviere JE
    Am J Vet Res; 1990 Mar; 51(3):399-403. PubMed ID: 2316917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetically determined cyclosporine dosage in young children.
    Hoppu K; Koskimies O; Holmberg C; Hirvisalo EL
    Pediatr Nephrol; 1991 Jan; 5(1):1-4. PubMed ID: 2025515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary fat on the pharmacokinetics and pharmacodynamics of cyclosporine in kidney transplant recipients.
    Tan KK; Trull AK; Uttridge JA; Metcalfe S; Heyes CS; Facey S; Evans DB
    Clin Pharmacol Ther; 1995 Apr; 57(4):425-33. PubMed ID: 7712671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of orally and intravenously administered cyclosporine in pre-kidney transplant patients.
    Aweeka FT; Tomlanovich SJ; Prueksaritanont T; Gupta SK; Benet LZ
    J Clin Pharmacol; 1994 Jan; 34(1):60-7. PubMed ID: 8132853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.
    Karlsson MO; Lindberg-Freijs A
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):293-311. PubMed ID: 2231321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine disposition in the dog. Comparison of radioimmunoassay with high-performance liquid chromatographic assay and pharmacokinetics following intravenous administration.
    Buice RG; Gurley BJ; Stentz FB; Sidhu P; McClellan T; Williams JW
    Transplantation; 1985 Nov; 40(5):483-8. PubMed ID: 4060219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the immune system on cyclosporine absorption.
    Luke DR
    Xenobiotica; 1991 Jun; 21(6):817-24. PubMed ID: 1949911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine pharmacokinetics in cats following topical ocular administration.
    Gregory CR; Hietala SK; Pedersen NC; Gregory TA; Floyd-Hawkins KA; Patz JD
    Transplantation; 1989 Mar; 47(3):516-9. PubMed ID: 2646782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.
    Bruelisauer A; Kawai R; Misslin P; Lemaire M
    Drug Metab Dispos; 1994; 22(2):194-9. PubMed ID: 8013274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Area under the curve monitoring of cyclosporine therapy: the early posttransplant period.
    Grevel J; Kahan BD
    Ther Drug Monit; 1991 Mar; 13(2):89-95. PubMed ID: 2053129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.